Columbus Hill Capital Management L.P. Purchases 30,132 Shares of Humana Inc. (NYSE:HUM)

Columbus Hill Capital Management L.P. boosted its position in shares of Humana Inc. (NYSE:HUM) by 36.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 112,622 shares of the insurance provider’s stock after acquiring an additional 30,132 shares during the quarter. Humana accounts for approximately 5.6% of Columbus Hill Capital Management L.P.’s investment portfolio, making the stock its 8th biggest holding. Columbus Hill Capital Management L.P. owned approximately 0.09% of Humana worth $28,573,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the company. FPC Investment Advisory Inc. acquired a new position in Humana during the fourth quarter worth approximately $27,000. Centricity Wealth Management LLC bought a new stake in Humana in the 4th quarter valued at $30,000. LFA Lugano Financial Advisors SA increased its holdings in shares of Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares during the last quarter. OFI Invest Asset Management bought a new stake in shares of Humana during the 4th quarter worth about $33,000. Finally, Atwood & Palmer Inc. raised its holdings in Humana by 64.5% in the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock valued at $39,000 after acquiring an additional 60 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Trading Down 4.6 %

NYSE HUM opened at $253.37 on Friday. The stock has a market capitalization of $30.58 billion, a P/E ratio of 25.46, a P/E/G ratio of 2.05 and a beta of 0.62. Humana Inc. has a one year low of $213.31 and a one year high of $406.46. The business has a 50 day simple moving average of $267.58 and a 200 day simple moving average of $271.85. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Research analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.40%. Humana’s dividend payout ratio (DPR) is currently 35.58%.

Analyst Upgrades and Downgrades

HUM has been the topic of several research reports. Morgan Stanley decreased their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 12th. Truist Financial lifted their target price on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a report on Monday, January 6th. Barclays boosted their price target on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a research note on Thursday, February 13th. JPMorgan Chase & Co. reduced their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 18th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $290.00 price target on shares of Humana in a research note on Wednesday, February 12th. Eighteen equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, Humana currently has an average rating of “Hold” and an average price target of $280.17.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.